Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 203

1.

Effectiveness of the traditional Japanese Kampo medicine Yokukansan for chronic migraine: A case report.

Akiyama H, Hasegawa Y.

Medicine (Baltimore). 2019 Sep;98(36):e17000. doi: 10.1097/MD.0000000000017000.

2.

Effect of Yokukansan for the Treatment of Idiopathic Rapid Eye Movement Sleep Behavior Disorder: A Retrospective Analysis of Consecutive Patients.

Matsui K, Sasai-Sakuma T, Ishigooka J, Nishimura K, Inoue Y.

J Clin Sleep Med. 2019 Aug 15;15(8):1173-1178. doi: 10.5664/jcsm.7816.

PMID:
31482840
3.

Abstracts from the 44th Annual Meeting of Japanese Society for Microcirculation.

Kajimura M.

Microcirculation. 2019 Jul 30. doi: 10.1111/micc.12583. [Epub ahead of print]

PMID:
31359544
4.

Comparison of the Effects of Yokukansan and Yokukansankachimpihange on Glutamate Uptake by Cultured Astrocytes and Glutamate-Induced Excitotoxicity in Cultured PC12 Cells.

Kawakami Z, Omiya Y, Mizoguchi K.

Evid Based Complement Alternat Med. 2019 May 27;2019:9139536. doi: 10.1155/2019/9139536. eCollection 2019.

5.

Yokukansan Alleviates Cancer Pain by Suppressing Matrix Metalloproteinase-9 in a Mouse Bone Metastasis Model.

Nakao K, Fujiwara A, Komasawa N, Jin D, Kitano M, Matsunami S, Takai S, Ito S, Minami T.

Evid Based Complement Alternat Med. 2019 May 26;2019:2956920. doi: 10.1155/2019/2956920. eCollection 2019.

6.

Yokukansan-induced reduction of ethanol preference is associated with antagonism of 5-HT3 receptors.

Nakamura Y, Kondo M, Koyama Y, Shimada S.

Phytomedicine. 2019 Jun;59:152897. doi: 10.1016/j.phymed.2019.152897. Epub 2019 Mar 20.

PMID:
30974311
7.

LC-MS/MS detection of citrus unshiu peel-derived flavonoids in the plasma and brain after oral administration of yokukansankachimpihange in rats.

Takiyama M, Matsumoto T, Watanabe J.

Xenobiotica. 2019 Feb 11:1-10. doi: 10.1080/00498254.2019.1581300. [Epub ahead of print]

PMID:
30741064
8.

Analyses of the possible anti-tumor effect of yokukansan.

Han C, Kawata M, Hamada Y, Kondo T, Wada J, Asano K, Makabe H, Igarashi K, Kuzumaki N, Narita M, Kobayashi H, Narita M.

J Nat Med. 2019 Jun;73(3):468-479. doi: 10.1007/s11418-019-01283-x. Epub 2019 Feb 9.

PMID:
30739283
9.

Yokukansan for perioperative psychiatric symptoms in cancer patients undergoing high invasive surgery. J-SUPPORT 1605 (ProD Study): study protocol for a randomized controlled trial.

Wada S, Sadahiro R, Matsuoka YJ, Uchitomi Y, Yamaguchi T, Shimizu K.

Trials. 2019 Feb 8;20(1):110. doi: 10.1186/s13063-019-3202-1.

10.

Potential Application of Yokukansan as a Remedy for Parkinson's Disease.

Jang JH, Jung K, Kim JS, Jung I, Yoo H, Moon C.

Evid Based Complement Alternat Med. 2018 Dec 20;2018:1875928. doi: 10.1155/2018/1875928. eCollection 2018. Review.

11.

Effect of Yokukansan on Nitric Oxide Production and Hydroxyl Radical Metabolism During Cerebral Ischemia and Reperfusion in Mice.

Kitabayashi C, Ito Y, Kawasaki H, Tanaka A, Nishioka R, Yamazato M, Ishizawa K, Nagai T, Hirayama M, Takahashi K, Yamamoto T, Araki N.

J Stroke Cerebrovasc Dis. 2019 May;28(5):1151-1159. doi: 10.1016/j.jstrokecerebrovasdis.2018.12.047. Epub 2019 Jan 14.

PMID:
30655039
12.

Traditional Japanese Herbal Medicine Yokukansan Targets Distinct but Overlapping Mechanisms in Aged Mice and in the 5xFAD Mouse Model of Alzheimer's Disease.

Kaushik R, Morkovin E, Schneeberg J, Confettura AD, Kreutz MR, Senkov O, Dityatev A.

Front Aging Neurosci. 2018 Dec 17;10:411. doi: 10.3389/fnagi.2018.00411. eCollection 2018.

13.

Basic Study of Drug-Drug Interaction between Memantine and the Traditional Japanese Kampo Medicine Yokukansan.

Matsumoto T, Sekiguchi K, Kawakami Z, Watanabe J, Mizoguchi K, Ikarashi Y, Yamamoto M.

Molecules. 2018 Dec 29;24(1). pii: E115. doi: 10.3390/molecules24010115.

14.

Yokukansan Ameliorates Hippocampus-Dependent Learning Impairment in Senescence-Accelerated Mouse.

Azuma K, Toyama T, Katano M, Kajimoto K, Hayashi S, Suzuki A, Tsugane H, Iinuma M, Kubo KY.

Biol Pharm Bull. 2018;41(10):1593-1599. doi: 10.1248/bpb.b18-00359.

15.
16.

Yokukansan (Kampo medicinal formula) prevents the development of morphine tolerance by inhibiting the secretion of orexin A.

Katayama A, Kanada Y, Tsukada M, Akanuma Y, Takemura H, Ono T, Suga H, Mera H, Hisamitsu T, Sunagawa M.

Integr Med Res. 2018 Jun;7(2):141-148. doi: 10.1016/j.imr.2018.02.005. Epub 2018 Mar 8.

17.
18.

Yokukansan, a Herbal Medicine in Japan, Buffers Social Crowding Stress via Ameliorating Glucocorticoid Secretion Response to Vasopressin.

Tamano H, Morioka H, Iwaki H, Suzuki H, Sato Y, Takeda A.

Biol Pharm Bull. 2018;41(6):920-924. doi: 10.1248/bpb.b18-00052.

19.

Yokukansan, a Traditional Japanese Medicine, Enhances the Glutamate Transporter GLT-1 Function in Cultured Rat Cortical Astrocytes.

Ueki T, Kawakami Z, Kanno H, Omiya Y, Mizoguchi K, Yamamoto M.

Evid Based Complement Alternat Med. 2018 May 6;2018:6804017. doi: 10.1155/2018/6804017. eCollection 2018.

20.

Use of a Caco-2 permeability assay to evaluate the effects of several Kampo medicines on the drug transporter P-glycoprotein.

Matsumoto T, Kaifuchi N, Mizuhara Y, Warabi E, Watanabe J.

J Nat Med. 2018 Sep;72(4):897-904. doi: 10.1007/s11418-018-1222-x. Epub 2018 May 24.

Supplemental Content

Loading ...
Support Center